The device was first used in gastric sleeve surgery Aug. 24, 2021, and Standard Bariatrics said Jan. 19 that surgeons using it are reporting less operative time and less postoperative patient nausea. It was cleared by the FDA in April 2021.
Standard Bariatrics said the Titan SGS reached $1 million in sales during November 2021, after less than six months on the market. Standard Bariatrics currently has multiple investors with a mix of series A and series B funding.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
